Abeona Therapeutics Officer Proposes Sale of 4,902 Shares

The remarks state that the shares were sold to cover taxes pursuant to a restricted stock award vesting event.

Rhea-AI Filing Summary

Abeona Therapeutics Inc. (ABEO) reports a Form 144 notice by officer Madhav Vasanthavada covering a proposed sale of 4,902 common shares, with an aggregate market value of $25,273. The approximate sale date is September 29, 2026; Stifel Nicolaus & Company Inc. is listed as broker, and Nasdaq as the exchange.

Key Figures

Proposed shares for sale: 4,902 shares Aggregate market value: $25,273 Restricted stock award shares: 9,700 shares +1 more

4 metrics

Proposed shares for sale 4,902 shares Common stock; approximate sale date September 29, 2026.

Aggregate market value $25,273 For the proposed sale of 4,902 common shares.

Restricted stock award shares 9,700 shares Listed with a September 29, 2026 date and equity compensation.

Shares sold during the past three months 12,606 shares Sale dated July 9, 2026.

Key Terms

Rule 144, Restricted Stock Awards, RSA vesting event

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Awards financial

"Common Stock | 09/29/2026 | Restricted Stock Awards"

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

RSA vesting event financial

"pursuant to an RSA vesting event"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why were the ABEO shares sold?

The remarks state that the shares were sold to cover taxes pursuant to a restricted stock award (RSA) vesting event.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/29/2026 - 04:48 PM Accepted by SEC EDGAR 09/29/2026 - 04:47 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002106295
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ABEONA THERAPEUTICS INC.
SEC File Number	001-15771
Address of Issuer	6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OHIO 44103
Phone	646-813-4701
Name of Person for Whose Account the Securities are To Be Sold	Vasanthavada Madhav
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	4902	25273.00	57184017	09/29/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/29/2026	Restricted Stock Awards	Issuer			9700	09/29/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Madhav Vasanthavada 6555 CARNEGIE AVE 4TH FLOOR CLEVELAND OH 44103	Common Stock	07/09/2026	12606	87784.00

144: Remarks and Signature

Remarks	These shares were sold to cover for taxes pursuant to an RSA vesting event.
Date of Notice	09/29/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Azad Daswani, as a duly authorized representative of STIFEL, as attorney-in-fact for Madhav Vasanthavada
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)